Clinical Trial Update: DHA Supplementation in Patients With STGD3 [NA]

View source ↗

Summary

This ClinicalTrials.gov entry reports a completed trial evaluating DHA (docosahexaenoic acid) supplementation in patients with Dominantly Inherited Stargardt's …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stargardt Disease

Drugs mentioned

• Docosahexaenoic acid (DHA) supplementation (docosahexaenoic acid)

Snippet

Sponsor: University of Utah | Conditions: Dominantly Inherited Stargardt's Disease (STGD3) | NA | Status: COMPLETED